Correlation Between Esperion Therapeutics and Citius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and Citius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and Citius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and Citius Pharmaceuticals, you can compare the effects of market volatilities on Esperion Therapeutics and Citius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of Citius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and Citius Pharmaceuticals.
Diversification Opportunities for Esperion Therapeutics and Citius Pharmaceuticals
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Esperion and Citius is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and Citius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Pharmaceuticals and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with Citius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Pharmaceuticals has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and Citius Pharmaceuticals go up and down completely randomly.
Pair Corralation between Esperion Therapeutics and Citius Pharmaceuticals
Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 0.6 times more return on investment than Citius Pharmaceuticals. However, Esperion Therapeutics is 1.68 times less risky than Citius Pharmaceuticals. It trades about 0.15 of its potential returns per unit of risk. Citius Pharmaceuticals is currently generating about -0.36 per unit of risk. If you would invest 252.00 in Esperion Therapeutics on September 12, 2024 and sell it today you would earn a total of 52.00 from holding Esperion Therapeutics or generate 20.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Esperion Therapeutics vs. Citius Pharmaceuticals
Performance |
| Timeline |
| Esperion Therapeutics |
| Citius Pharmaceuticals |
Esperion Therapeutics and Citius Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Esperion Therapeutics and Citius Pharmaceuticals
The main advantage of trading using opposite Esperion Therapeutics and Citius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, Citius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Pharmaceuticals will offset losses from the drop in Citius Pharmaceuticals' long position.| Esperion Therapeutics vs. Evoke Pharma | Esperion Therapeutics vs. Lantheus Holdings | Esperion Therapeutics vs. ANI Pharmaceuticals | Esperion Therapeutics vs. Ironwood Pharmaceuticals |
| Citius Pharmaceuticals vs. X4 Pharmaceuticals | Citius Pharmaceuticals vs. Hookipa Pharma | Citius Pharmaceuticals vs. Mereo BioPharma Group | Citius Pharmaceuticals vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |